register

Medical and Science

Aussie experts sign WHO’s COVID-19 vaccine pledge

Health Industry Hub | April 15, 2020 |

Medical News: As part of World Health Organisation’s (WHO) response to the COVID-19 outbreak, a Research and Development (R&D) Blueprint has been activated to accelerate the development of diagnostics, vaccines and therapeutics for this novel coronavirus.

Australian researchers working on COVID-19 vaccines have signed a WHO declaration pledging global collaboration to develop a COVID-19 vaccine. The statement applauds the community intervention measures that have taken place, with scientist pledging to use the time gained by the implementation of these measures to develop a vaccine as rapidly as possible. The pledge promises to strengthen the unprecedented worldwide collaboration, cooperation and sharing of data already underway.

Declaration

“We are scientists, physicians, funders and manufacturers who have come together as part of an international collaboration, coordinated by the World Health Organisation (WHO), to help speed the availability of a vaccine against COVID-19. While a vaccine for general use takes time to develop, a vaccine may ultimately be instrumental in controlling this worldwide pandemic. In the interim, we applaud the implementation of community intervention measures that reduce spread of the virus and protect people, including vulnerable populations, and pledge to use the time gained by the widespread adoption of such measures to develop a vaccine as rapidly as possible. We will continue efforts to strengthen the unprecedented worldwide collaboration, cooperation and sharing of data already underway. We believe these efforts will help reduce inefficiencies and duplication of effort, and we will work tenaciously to increase the likelihood that one or more safe and effective vaccines will soon be made available to all.”

Australian Experts in Worldwide Collaboration

  • Keith Chappell, University of Queensland        
  • Damian Purcell, Doherty Institute for Infection and Immunity
  • Paul R Young, University of Queensland

Register FREE and join 20,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

You may also like Customer-Centric Engagement During COVID-19


News - Pharmaceuticals

New funding to bring global CAR-T trials to young cancer patients

New funding to bring global CAR-T trials to young cancer patients

Health Industry Hub | September 14, 2026 |

The government is delivering the first investment under the $300 million MRFF Australian Cancer Research Program (ACRP), to bring international […]

More


News - Pharmaceuticals

Rising gynae cancers meets a system forcing patients to pay the price

Rising gynae cancers meets a system forcing patients to pay the price

Health Industry Hub | September 14, 2026 |

Sector leaders, government and women with lived experience unite in Canberra today to accelerate evidence-based action, as gynaecological cancer diagnoses […]

More


News - MedTech & Diagnostics

Analysis confirms private health insurance cuts targets vulnerable pensioners

Analysis confirms private health insurance cuts target vulnerable pensioners

Health Industry Hub | September 14, 2026 |

New analysis by the Parliamentary Budget Office (PBO) shows that half of the $3 billion dollars the Albanese Government expects […]

More


News - MedTech & Diagnostics

Chalmers retreats as startup tax backlash forces further changes

Chalmers retreats as startup tax backlash forces further changes

Health Industry Hub | September 14, 2026 |

The Albanese Government has been forced to retreat from several of the most contentious elements of its proposed startup tax […]

More


This content is copyright protected. Please subscribe to gain access.